Fundz

Who to call at BIAL, and when

Fundz watches for the moments BIAL starts buying, and tells you who to reach.

  • An alert the day BIAL raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BIAL, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BIAL. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchBIAL Reports Successful First Patient Completion in Phase 2 Study of BIA 28-6156 for GBA1 Parkinson's Disease Treatment

Jan 07, 2025
PortugalBiotechnologyHealth CareTherapeuticsBiopharma

Product Description

BIAL announced the completion of the full dose regimen by the first patient in their ACTIVATE Phase 2 clinical trial for BIA 28-6156, a novel treatment for patients with Parkinson's disease caused by GBA1 gene mutations. This milestone is seen as significant in the development of a disease-modifying therapy for GBA-PD.

Company Information

Company

BIAL

Location

Portugal

About

BIAL is a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases. It is dedicated to the development of novel therapies that aim to improve patient care, particularly in neurodegenerative diseases. With a strong emphasis on research and development, BIAL seeks to create transformative value for those affected by such conditions. The company is committed to advancing treatment options through effective and innovative solutions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BIAL ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BIAL's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

BIAL shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.